EFICACY AND SAFETY OF FLECAINIDE TO REDUCE EXERCISE-INDUCED VENTRICULAR ARRHYTHMIAS AND THE ARRHYTHMIC WINDOW IN PATIENTS WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA

Authors :: María del Val Groba Marco
Josep Brugada
Eduardo Caballero Dorta
Luis Álvarez Acosta
Fernando Wangüemert Pérez
Guillermo J. Pérez
Ramon Brugada-Terradellas
Oscar Campuzano Larrea
Julio Salvador Hernández Afonso
Source :: Journal of the American College of Cardiology. 69:330
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.
Abstract: Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited disease characterized by ventricular arrhythmias (VA) triggered in a situation of physical or emotional stress in young people with structurally normal heart. The cornerstone of the treatment are the beta

Subjects :: medicine.medical_specialty
business.industry
Emotional stress
Catecholaminergic polymorphic ventricular tachycardia
medicine.disease
Internal medicine
cardiovascular system
medicine
Cardiology
In patient
cardiovascular diseases
Inherited disease
Cardiology and Cardiovascular Medicine
business
Beta (finance)
Flecainide
Normal heart
medicine.drug

Full Text Access

Tools